Ami Organics inks definitive agreement with Fermion

15 Dec 2023 Evaluate

Ami Organics has signed definitive agreement with Fermion, a fully owned subsidiary of Orion Corporation, Finland. As part of the agreement, the company will manufacture couple of additional advanced pharmaceutical intermediates for Fermion. The two additional advanced pharmaceutical intermediates signed will be used in captive consumption for the manufacture of earlier advanced pharmaceutical intermediates signed with Fermion. 

This agreement will lead to value addition to the final advanced intermediates which will be supplied by Ami Organics to Fermion, leading to higher value of end product. This will also help company become leading supplier of Fermion, supplying key advanced intermediates. The products are slated to be manufactured at the Ankleshwar Facility and are expected to start contributing meaningfully to the revenue from FY25.

Ami Organics is one of the leading research and development driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical ingredients (API) for New Chemical Entities, and material for agrochemicals and fine chemicals.

AMI Organics Share Price

2118.55 21.15 (1.01%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.